{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT03466021","recordId":"NCT03466021","peptideSlug":"liraglutide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct03466021-liraglutide/","json":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct03466021.json","markdown":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct03466021.md"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2018-03-08","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2018-03-08","publishedAt":"2026-08-23","recordId":"NCT03466021","recordSha256":"144ffebdf650695ca0e35f02aaaeb274aaaef1f6b3a04a51f0827bbfc6275e41","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03466021?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Arms and Interventions","Eligibility","Outcome Measures","Study Description","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2018-03-15","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2018-03-15","publishedAt":"2026-08-23","recordId":"NCT03466021","recordSha256":"44bc8ef3c8fcad6636bbb2153882182c554021221328e2e9c36db052d94448d6","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03466021?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Design","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2021-03-12","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2021-03-12","publishedAt":"2026-08-23","recordId":"NCT03466021","recordSha256":"36cb6ed5d7d9ff67072857cbafa70f105032cfe295490e8077506c88b0924d06","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03466021?a=3&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"8ec8fc76266d15e47aa3307d6b956a495d6e5c35126192f927f8f25445dcf0e4"}}